Ownership

Jacob Chacko - Insider Trading & Ownership

Entity: Individual
Location: C/O Ignyta, Inc., 11095 Flintkote Ave., Suite D, San Diego, CA
Summary: The estimated net worth of Jacob Chacko is at least $8.01M dollars as of January 3, 2025. Jacob Chacko is the PRESIDENT AND CEO, Director of Oric Pharmaceuticals, Inc. and owns shares of Oric Pharmaceuticals, Inc. (ORIC) stock worth about $8.01M.
All Insider Reports: All Insider Reports

Ownership of Jacob Chacko

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ORIC	Oric Pharmaceuticals, Inc.	PRESIDENT AND CEO, Director	$8.01M	-$204K	-2.49%	Jan 2, 2025
FDMT	4D Molecular Therapeutics, Inc.	Director				May 21, 2024

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Jacob Chacko:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
ORIC	Oric Pharmaceuticals, Inc.	Restricted Stock Unit	Award		$0	0.00	+100K	100K	1/2/2025	Direct
ORIC	Oric Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+600K	600K	1/2/2025	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-3.07%	-$204K	8.28	-24.7K	779K	12/16/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Options Exercise	+9.1%	$0	0.00	+67K	803K	12/15/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Restricted Stock Unit	Options Exercise	-100%	$0	0.00	-67K	0	12/15/2024	Direct
FDMT	4D Molecular Therapeutics, Inc.	Stock Option (Right To Buy)	Award		$0	0.00	+22.5K	22.5K	5/21/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-5.2%	-$648K	16.21	-40K	729K	3/6/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-3.28%	-$320K	12.29	-26K	769K	2/7/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-1.73%	-$169K	12.12	-14K	795K	2/6/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+510K	510K	1/2/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Restricted Stock Unit	Award		$0	0.00	+85K	85K	1/2/2024	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-1.77%	-$125K	8.58	-14.5K	809K	12/15/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Options Exercise	+4.93%	$0	0.00	+38.7K	823K	12/15/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Restricted Stock Unit	Options Exercise	-69.9%	$0	0.00	-38.7K	16.7K	12/15/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-0.66%	-$41.3K	8.01	-5.16K	781K	7/11/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-1.32%	-$84.2K	8.01	-10.5K	786K	7/10/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-0.54%	-$34.7K	8.01	-4.34K	796K	7/5/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-2.44%	-$161K	8.03	-20K	801K	6/26/2023	Direct
FDMT	4D Molecular Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+22.5K	22.5K	5/23/2023	Direct
FDMT	4D Molecular Therapeutics, Inc.	Common Stock	Sale	-100%	-$100K	20.05	-5K	0	4/21/2023	Direct
FDMT	4D Molecular Therapeutics, Inc.	Common Stock	Options Exercise		$47.1K	9.41	+5K	5K	4/21/2023	Direct
FDMT	4D Molecular Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-13.3%	$0	0.00	-5K	32.5K	4/21/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+400K	400K	2/1/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Restricted Stock Unit	Award		$0	0.00	+66K	66K	2/1/2023	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-0.75%	-$18.9K	3.07	-6.14K	817K	12/15/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0		+1.02M	438K	7/20/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Stock Option (right to buy)	Disposed to Issuer	-100%	$0		-1.02M	0	7/20/2022	Direct
FDMT	4D Molecular Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+22.5K	22.5K	5/23/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Purchase	+10.5%	$215K	2.82	+76.1K	803K	5/13/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Purchase	+10.6%	$190K	2.75	+69.4K	727K	5/12/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Purchase	+86.4%	$884K	2.90	+305K	657K	5/11/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Purchase	+16.5%	$227K	4.54	+50K	353K	3/25/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Purchase	+16.5%	$216K	5.03	+42.9K	303K	3/24/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Purchase	+9695.6%	$1.28M	4.98	+257K	260K	3/23/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+300K	300K	2/1/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Restricted Stock Unit	Award		$0	0.00	+50K	50K	2/1/2022	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-58.5%	-$93.6K	25.06	-3.74K	2.65K	9/15/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-40.9%	-$111K	25.05	-4.42K	6.39K	9/14/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-20.6%	-$70.1K	25.02	-2.8K	10.8K	9/13/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-17.8%	-$73.8K	25.08	-2.94K	13.6K	9/10/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-1.19%	-$5.01K	25.04	-200	16.6K	9/8/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-26.3%	-$150K	25.11	-5.98K	16.8K	9/7/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-1.73%	-$10K	25.07	-400	22.7K	5/27/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-0.05%	-$300	25.00	-12	23.1K	5/24/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-17.1%	-$121K	25.20	-4.79K	23.1K	5/21/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-8.12%	-$61.9K	25.07	-2.47K	27.9K	5/20/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-27.1%	-$288K	25.38	-11.3K	30.4K	5/18/2021	Direct
FDMT	4D Molecular Therapeutics Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+22.5K	22.5K	5/17/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-5.76%	-$63.9K	25.05	-2.55K	41.7K	5/17/2021	Direct
ORIC	Oric Pharmaceuticals, Inc.	Common Stock	Sale	-23.9%	-$352K	25.36	-13.9K	44.3K	5/14/2021	Direct

Previous1 2Next

Showing 1 to 50 of 53 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.